FYD-33907-84308
3 vaccinations
2 coded responses
44 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 531 / WI
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
P2A-32518-85226
Child or adolescent in my care · Female · 2022-07-26
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-21
- 2021-04-26
- 2021-05-03
- 2021-06-22
- 2021-09-20
-
2021-11-26
Dose 2 — Moderna
-
2021-11-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-12
- 2021-12-17
- 2021-12-24
- 2021-12-31
-
2022-01-07
Survey response — day 42, dose 2MedDRA: Bronchitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: BronchitisMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-10
- 2022-02-25
- 2022-05-27
- 2022-11-26
-
2022-11-30
Dose 3 — Moderna
-
2022-12-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-12-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-12-03
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2022-12-04
- 2022-12-05
- 2022-12-06
- 2022-12-07
- 2022-12-14
- 2022-12-21
- 2022-12-28
- 2023-01-04
- 2023-01-11
- 2023-03-01
- 2023-05-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-26 | Moderna | No |
| 3 | 2022-11-30 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 42, dose 2
Symptoms: Bronchitis
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release